Pro- and anti-inflammatory cytokine concentrations and their influence on therapy outcome in female patients with post-traumatic stress disorder
Vanessa Renner
DOI: https://doi.org/10.1016/j.psyneuen.2023.106749
IF: 4.693
2024-02-01
Psychoneuroendocrinology
Abstract:Background Alterations of the hypothalamus pituitary-axis on one hand and heightened rates of somatic diseases on the other hand are consistently found for PTSD patients. A possible link between these factors might be the immune system, in particular pro- and anti-inflammatory cytokines, which could also influence therapy outcome. Methods Female PTSD patients (n = 17) participated in the Trier social stress test before therapeutic treatment. Serum cytokine levels (IL-6, IL-10) were assessed and compared with female depressive patients (n = 18) and female healthy controls (n = 18). Group differences were assessed using repeated measures ANCOVA with baseline values as covariates. Areas under the curve with respect to ground (AUCG) and increase (AUCI) for cytokine levels during the TSST were calculated and used as predictors in regression analyses with pre-treatment scores for the prediction of therapy outcome. Results PTSD patients showed higher IL-10 levels compared with depressive patients (p <.001, d = 0.16) and healthy controls (p =.001, d = 0.38). Models including AUCG and AUCI scores showed superior fits compared with models including pre-treatment scores alone (ΔR2 =.196 to.444). IL-6 AUCG and AUCI scores were significant predictors for post-treatment SCL-GSI and BDI (β = -.554 to.853). IL-10 AUCG significantly predicted SCL-GSI and BDI (β = -.449 to -.509). Conclusion The results hint at an imbalance of pro- and anti-inflammatory cytokine levels in PTSD, which influences therapy outcome. This should be addressed in future studies investigating underlying mechanisms.
neurosciences,endocrinology & metabolism,psychiatry
What problem does this paper attempt to address?